Ivabradine and Milrinone—Bridge to Recovery in New HFrEF With Low-Output Heart Failure
In patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) who are on a downward clinical trajectory, options are mostly limited to left ventricular assist device and transplantation. However, in those with factors favorable for reverse remodeling, every effort should be m...
Saved in:
Main Authors: | Lekha Racharla, Lucas Gitzel, Max Joseph, Desire Guthier, Nael Hawwa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2024/5278240 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of carvedilol vs. bisoprolol for heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis from the Asian population
by: Yedy Purwandi Sukmawan, et al.
Published: (2025-01-01) -
Patterns of beta-blocker use and dose optimization among ambulatory heart failure patients with reduced ejection fraction (HFrEF) attending public hospitals in Northeast Ethiopia: a multi-center cross-sectional study
by: Minimize Hassen, et al.
Published: (2025-01-01) -
Comparison of Milrinone with Sildenafil for the Treatment of Persistent Pulmonary Hypertension of the Newborn
by: Imtiaz Ahmad, et al.
Published: (2024-06-01) -
Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
by: Lukasz Szarpak, et al.
Published: (2022-06-01) -
Inhaled milrinone for the management of severe pulmonary hypertension in non-cardiac surgery
by: Philip Stamov, et al.
Published: (2024-11-01)